1. Home
  2. OCUL vs MRX Comparison

OCUL vs MRX Comparison

Compare OCUL & MRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • MRX
  • Stock Information
  • Founded
  • OCUL 2006
  • MRX 2005
  • Country
  • OCUL United States
  • MRX United Kingdom
  • Employees
  • OCUL N/A
  • MRX N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • MRX
  • Sector
  • OCUL Health Care
  • MRX
  • Exchange
  • OCUL Nasdaq
  • MRX NYSE
  • Market Cap
  • OCUL 1.4B
  • MRX 1.6B
  • IPO Year
  • OCUL 2014
  • MRX 2024
  • Fundamental
  • Price
  • OCUL $9.16
  • MRX $28.34
  • Analyst Decision
  • OCUL Strong Buy
  • MRX Strong Buy
  • Analyst Count
  • OCUL 8
  • MRX 7
  • Target Price
  • OCUL $16.50
  • MRX $30.71
  • AVG Volume (30 Days)
  • OCUL 889.3K
  • MRX 709.4K
  • Earning Date
  • OCUL 11-14-2024
  • MRX 11-07-2024
  • Dividend Yield
  • OCUL N/A
  • MRX 0.49%
  • EPS Growth
  • OCUL N/A
  • MRX 2.80
  • EPS
  • OCUL N/A
  • MRX 2.51
  • Revenue
  • OCUL $61,442,000.00
  • MRX $1,539,450,000.00
  • Revenue This Year
  • OCUL $15.49
  • MRX N/A
  • Revenue Next Year
  • OCUL $13.31
  • MRX $5.45
  • P/E Ratio
  • OCUL N/A
  • MRX $11.28
  • Revenue Growth
  • OCUL 6.45
  • MRX N/A
  • 52 Week Low
  • OCUL $2.05
  • MRX $18.13
  • 52 Week High
  • OCUL $11.78
  • MRX $29.26
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 34.86
  • MRX N/A
  • Support Level
  • OCUL $10.46
  • MRX N/A
  • Resistance Level
  • OCUL $11.12
  • MRX N/A
  • Average True Range (ATR)
  • OCUL 0.57
  • MRX 0.00
  • MACD
  • OCUL -0.22
  • MRX 0.00
  • Stochastic Oscillator
  • OCUL 0.60
  • MRX 0.00

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About MRX MAREX GROUP PLC

Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.

Share on Social Networks: